Discover the booming injectable ketamine market, projected to reach $6.27 billion by 2033, with a 16% CAGR. This comprehensive analysis explores market drivers, trends, and key players, including Pfizer and Greenco Biologicals, providing insights into this rapidly expanding sector for treatment-resistant depression and anesthesia.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
